31.23
1.92%
-0.61
After Hours:
31.18
-0.05
-0.16%
Sanara MedTech Inc stock is currently priced at $31.23, with a 24-hour trading volume of 7,399.
It has seen a -1.92% decreased in the last 24 hours and a -14.32% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $31.81 pivot point. If it approaches the $31.13 support level, significant changes may occur.
Previous Close:
$31.84
Open:
$31.5353
24h Volume:
7,399
Market Cap:
$269.29M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-29.74
EPS:
-1.05
Net Cash Flow:
$-3.51M
1W Performance:
-3.91%
1M Performance:
-14.32%
6M Performance:
+16.92%
1Y Performance:
-21.49%
Sanara MedTech Inc Stock (SMTI) Company Profile
Name
Sanara MedTech Inc
Sector
Industry
Phone
817 529 2300
Address
1200 Summit Avenue, Suite 414, Fort Worth
Sanara MedTech Inc Stock (SMTI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara MedTech Inc Stock (SMTI) Latest News
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
GlobeNewswire Inc.
Sanara MedTech Inc. Announces $55 Million Debt Facility
GlobeNewswire Inc.
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
GlobeNewswire Inc.
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
GlobeNewswire Inc.
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
GlobeNewswire Inc.
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
GlobeNewswire Inc.
Sanara MedTech Inc Stock (SMTI) Financials Data
Sanara MedTech Inc (SMTI) Revenue 2024
SMTI reported a revenue (TTM) of $64.99 million for the quarter ending December 31, 2023, a +41.77% rise year-over-year.
Sanara MedTech Inc (SMTI) Net Income 2024
SMTI net income (TTM) was -$4.30 million for the quarter ending December 31, 2023, a +45.79% increase year-over-year.
Sanara MedTech Inc (SMTI) Cash Flow 2024
SMTI recorded a free cash flow (TTM) of -$3.51 million for the quarter ending December 31, 2023, a +44.29% increase year-over-year.
Sanara MedTech Inc (SMTI) Earnings per Share 2024
SMTI earnings per share (TTM) was -$0.52 for the quarter ending December 31, 2023, a +48.51% growth year-over-year.
About Sanara MedTech Inc
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. It also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers; and PULSAR II Advanced Wound Irrigation System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Cap:
|
Volume (24h):